Press

In November 2017, Asana Medical, Inc. announced that they had formally changed their name to Regentys, as a more distinctive representation of their business model and underlying regenerative medicine technology.

Asana Medical, Inc. CEO Dr. Christine V. Sapan to Present at 2016 BIO International Convention June 8th

June 1, 2016

Sapan to Provide Data Findings and Analysis from Company’s Recent Pivotal Preclinical Study

Read More →

Asana Medical, Inc. Adds Dr. Hal K. Wrigley to Board of Directors

May 18, 2016

Dr. Hal Wrigley, a dentist by trade and entrepreneur, has joined the Company’s Board of Directors.

Read More →

Asana Medical, Inc. Announces Closing of $1.2 Million Convertible Promissory Note Offering

May 10, 2016

Asana has closed a $1.2 million offering of convertible promissory notes. Asana, an emerging life sciences company, is focused on the development and commercialization of an innovative therapy to non-surgically treat Inflammatory Bowel Diseases (“IBD”), including Ulcerative Colitis (“UC”), Crohn’s Disease and Rectal Mucositis.

Read More →

Asana Medical, Inc. Names Dr. Christine V. Sapan CEO, Adds University of Miami’s Sergio M. Gonzalez to its Board of Directors

March 2, 2016

Dr. Christine V. Sapan has been named Chief Executive Officer of Asana Medical, Inc. Dr. Sapan, previously Asana’s President, will continue guiding the Company in the development of its first-in-class, tissue engineered treatment for IBD, a disease affecting as many as 1.6 million Americans and more than 5 million people worldwide.

Read More →

Dr. Christine V. Sapan Named President of Asana Medical, Inc.

Nov. 9, 2015

Dr. Christine V. Sapan has been named President of Asana Medical, Inc. Dr. Sapan will assume the role and responsibilities of Marc Ramer, Founder and former CEO. Dr. Sapan will assume the leadership role at Asana, and will guide the Company in the continuing development of its first-in-class, tissue engineered treatment for IBD, a disease affecting as many as 1.6 million Americans and more than 5 million people worldwide.

Read More →